Pennsylvania is getting pretty serious about weed for opioid dependency.
It will become the first state to regulate a cannabis research program, and eight medical schools across the state will receive clinical licenses to study weed’s healing effects — an area which many say lacks research.
“Today, medical research is so limited by the federal government that only a few doctors can even have access to medical marijuana,” stated Pennsylvania governor Tom Wolf. “Pennsylvania’s premiere medical schools will be able to help shape the future of treatment for patients who are in desperate need, not just here, but across the country.”
Pennsylvania is only the second state after New Jersey to allow the treatment of opioid use disorder under it medical cannabis program. The new law classifying opioid addiction as a qualifying condition to participate in the state’s medical cannabis program takes effect May 17, 2018.
In Philadelphia alone during 2017, 1,486 people died from drug overdoses. Along with permitting this research, Pennsylvania will also expand its three-month-old medical cannabis program to include cannabis sold in bid form, as well as reversing the chronic pain condition, so that it no longer requires patients to try opioid therapy before trying medical cannabis.